Latest news
Loading news…
Syndex Bio
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Cambridgeshire, United Kingdom Founded 2022 1-10 employees For Profit
Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
3
Patents
1
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- Patents granted
- 1
- Trademarks
- 1
- IT spend
- $9M
Company Info
- Founded
- 2022
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 8
- HQ
- Cambridge, Cambridgeshire, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- -0.1
- Trend (30d)
- -1
- Trend (90d)
- -4.2
- Last leadership hire
- Feb 22, 2026
Key People at Syndex Bio
CEO and Founder
3
professional contacts at Syndex Bio
Contact execs at Syndex Bio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Syndex Bio
Loading news…
FAQs about Syndex Bio
People who checked this page also checked these
Browse the full Acquirezy directory.